Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice
December 29th, 2016
11.4K views
Surgical occlusion of a distal middle cerebral artery branch (MCAo) is a frequently used model in experimental stroke research. This manuscript describes the basic technique of permanent MCAo, combined with the insertion of a lateral cranial window, which offers the opportunity for longitudinal intravital microscopy in mice.
Overview
This article describes a technique for preparing a lateral cranial window combined with permanent middle cerebral artery occlusion (MCAo) in mice. This method facilitates longitudinal intravital microscopy, allowing researchers to investigate changes following stroke.
Key Study Components
Area of Science
- Neuroscience
- Stroke Research
- Intravital Microscopy
Background
- Surgical occlusion of a distal middle cerebral artery branch is a common model in stroke research.
- The technique allows for the study of cerebellar ischemia.
- In vivo imaging provides insights into acute and chronic changes post-stroke.
- Understanding these changes is crucial for developing therapeutic strategies.
Purpose of Study
- To prepare a lateral cranial window for imaging.
- To perform permanent MCAo in mice.
- To enable longitudinal studies of ischemic changes.
Methods Used
- Administer anesthesia according to approved protocols.
- Ensure a surgical plane of anesthesia is achieved.
- Perform the surgical procedure to create the cranial window.
- Conduct permanent MCAo to study ischemic effects.
Main Results
- The technique allows for real-time imaging of ischemic changes.
- It provides a platform for investigating the effects of stroke over time.
- Longitudinal studies can reveal critical insights into recovery processes.
- In vivo imaging enhances understanding of stroke pathology.
Conclusions
- The combined technique is valuable for stroke research.
- It supports the investigation of both acute and chronic ischemic changes.
- This method can lead to advancements in therapeutic approaches for stroke.
Frequently Asked Questions
What is the main advantage of this technique?
The main advantage is the ability to perform in vivo imaging of acute and chronic changes after stroke.
How is anesthesia administered?
Anesthesia is administered according to an approved animal protocol, ensuring a surgical plane is reached.
What does MCAo stand for?
MCAo stands for middle cerebral artery occlusion, a model used in stroke research.
Why is longitudinal intravital microscopy important?
It allows researchers to observe changes over time in the same subject, providing valuable insights.
What type of animal is used in this procedure?
Mice are used for this surgical procedure and imaging technique.
What is the purpose of the lateral cranial window?
The lateral cranial window allows for direct observation of the brain during the study.
Executive Industry Relevance
This technique enables longitudinal intravital imaging of stroke pathology in mice, supporting mechanistic de-risking in preclinical stroke research. By combining chronic cranial window preparation with distal MCA occlusion, it provides a reproducible platform for evaluating neurovascular and cellular responses over time. This approach enhances predictive confidence in target validation and therapeutic screening for ischemic injury.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through real-time observation of ischemic lesion evolution.
- Operational Value: Supports biological de-risking by visualizing acute and chronic changes in neurovascular units.
- Predictive Value: Facilitates assessment of target engagement and pathway modulation in disease-relevant cortical regions.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream intravital microscopy and molecular imaging assays.
- Operational Value: Ensures assay standardization and reproducibility via stable cranial window preparation and consistent occlusion methodology.
- Scalability: Enables platform reuse for sequential imaging sessions across acute and chronic phases.
Translational & Preclinical Research
- Scientific Value: Maintains disease relevance by modeling cortical ischemia that spares striatum, mirroring human distal MCA stroke pathology.
- Translational Continuity: Bridges discovery through preclinical validation by enabling longitudinal tracking of infarct progression and recovery.
- Risk-Adjusted Decisions: Supports go/no-go evaluations based on quantifiable infarct volume and vascular dynamics over time.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target validation through preclinical efficacy assessment, enabling iterative imaging of ischemic changes.
- Discovery Biology: Supports hypothesis testing and pathway clarification via direct visualization of cortical vasculature and lesion development.
- Screening: Delivers assay readiness through reproducible cranial window preparation and standardized MCAo induction.
- Analytics: Provides quantitative outputs including infarct volume measurements via MRI and vascular dynamics via two-photon microscopy.
- Translational Research: Connects to preclinical continuity by allowing repeated imaging sessions to monitor recovery trajectories.
- Enterprise Reuse: Establishes a reusable imaging platform for multiple readouts across drug candidates and timepoints.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through direct observation of ischemic mechanisms.
- Operational Value: Standardization, reproducibility, and scalability of chronic cranial window preparation and occlusion procedures.
- Strategic Value: Improved go/no-go decisions, capital efficiency, and reduced late-stage biological risk in stroke therapeutics.
- Portfolio Impact: Risk-adjusted prioritization based on longitudinal infarct evolution and vascular recovery metrics.
Implementation Considerations
- Requires expertise in microsurgery, anesthesia management, and intravital microscopy techniques.
- Dependent on specialized instrumentation including stereotaxic frames, microdrills, bipolar forceps, and imaging systems.
- Necessitates cross-team standardization between surgical, imaging, and analysis groups for consistent outcomes.
- Adaptation considerations include variations in mouse strain, skull thickness, and vascular anatomy affecting window placement and occlusion efficacy.
- Practical limitations include surgical skill dependency and post-operative care requirements to maintain window integrity and animal welfare.
Biopharma FAQs
Why does permanent MCA occlusion matter for target validation in stroke models?
Permanent MCA occlusion creates a stable ischemic lesion that enables consistent evaluation of therapeutic interventions over time. This model supports reliable assessment of target engagement in cortical regions affected by stroke. Lesion stability is critical for reproducible preclinical target validation studies.
How does cranial window preparation enable longitudinal intravital microscopy in drug discovery?
The chronic cranial window provides optical access to the brain for repeated imaging sessions without repeated surgeries. This allows tracking of acute and chronic ischemic changes in the same animal across days or weeks. Longitudinal imaging reduces variability and increases statistical power in preclinical efficacy studies.
What quantitative measurements from infarct volume assessment enable go/no-go decisions?
Infarct volume measured via MRI at 24 and 96 hours post-ischemia provides quantifiable endpoints for evaluating lesion progression or protection. Mean lesion volumes of 13.16 mm³ at 24 hours and 12.2 mm³ at 96 hours demonstrate model consistency. These metrics support objective comparison across treatment groups in therapeutic screening.
Why are replication requirements important for cross-functional collaboration in stroke research?
High reproducibility of lesion volume and low mortality rates ensure reliable data transfer between surgical, imaging, and pharmacology teams. Consistent outcomes allow imaging teams to plan sessions with confidence in lesion presence and location. Reproducibility strengthens confidence in shared datasets used for target prioritization and mechanism confirmation.
What statistical analysis capabilities are required before implementing this model in therapeutic screening?
Implementation requires the ability to analyze longitudinal infarct volume changes and vascular dynamics from imaging data. Statistical comparison of lesion progression across groups depends on consistent MRI and two-photon microscopy readouts. Predefined thresholds for infarct reduction or vascular recovery are essential for objective go/no-go criteria in preclinical programs.
